Discontinuation of adjuvant hormone therapy among breast cancer patients not previously attending mammography screening.

ABSTRACT: BACKGROUND:Breast cancer patients who have not previously attended mammography screening may be more likely to discontinue adjuvant hormone therapy and therefore have a worse disease prognosis. METHODS:We conducted a population-based cohort study using data from Stockholm Mammography Screening Program, Stockholm-Gotland Breast Cancer Register, Swedish Prescribed Drug Register, and Swedish Cause of Death Register. Women in Stockholm who were diagnosed with breast cancer between 2001 and 2008 were followed until December 31, 2015. Non-participants of mammography screening were defined as women who, prior to their breast cancer diagnosis, were invited for mammography screening but did not attend. RESULTS:Of the 5098 eligible breast cancer patients, 4156 were defined as screening participants

SUBMITTER: He W 

PROVIDER: S-EPMC6354407 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature